Nancy Mendenhall, MD, at the University of Florida Proton Therapy Institute, and Ronald Chen, MD, at the University of North Carolina at Chapel Hill, were awarded $11.9 million to directly compare the potential benefits and harms of proton therapy to standard radiation therapy when treating prostate cancer.